Cargando…

Assessment of Vascular Event Prevention and Cognitive Function Among Older Adults With Preexisting Vascular Disease or Diabetes: A Secondary Analysis of 3 Randomized Clinical Trials

IMPORTANCE: Acquisition of reliable randomized clinical trial evidence of the effects of cardiovascular interventions on cognitive decline is a priority. OBJECTIVES: To estimate the association of cognitive aging with the avoidance of vascular events in cardiovascular intervention trials and underst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Offer, Alison, Arnold, Matthew, Clarke, Robert, Bennett, Derrick, Bowman, Louise, Bulbulia, Richard, Haynes, Richard, Li, Jing, Hopewell, Jemma C., Landray, Martin, Armitage, Jane, Collins, Rory, Parish, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484650/ https://www.ncbi.nlm.nih.gov/pubmed/30821829 http://dx.doi.org/10.1001/jamanetworkopen.2019.0223

Ejemplares similares

Independent risk factors for simvastatin-related myopathy and relevance to different types of muscle symptom
por: Hopewell, Jemma C, et al.
Publicado: (2020)

Comparison of the Accuracy and Completeness of Records of Serious Vascular Events in Routinely Collected Data vs Clinical Trial–Adjudicated Direct Follow-up Data in the UK: Secondary Analysis of the ASCEND Randomized Clinical Trial
por: Harper, Charlie, et al.
Publicado: (2021)

Impact of Apolipoprotein(a) Isoform Size on Lipoprotein(a) Lowering in the HPS2-THRIVE Study
por: Parish, Sarah, et al.
Publicado: (2018)

Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study
por: Hopewell, Jemma C., et al.
Publicado: (2013)

Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial
por: Parish, Sarah, et al.
Publicado: (2022)

Weight loss in a cardiovascular trial population identifies people at future risk of dementia
por: van der Veere, Pieter, et al.
Publicado: (2022)

Can vascular mortality be reliably ascertained from the underlying cause of death recorded on a medical death certificate? Evidence from 2800 adjudicated heart protection study (HPS) deaths
por: Herrington, William, et al.
Publicado: (2015)

Investigating modifications to participant information materials to improve recruitment into a large randomized trial
por: Haynes, Richard, et al.
Publicado: (2019)

A key risk indicator approach to central statistical monitoring in multicentre clinical trials: method development in the context of an ongoing large-scale randomized trial
por: Elsa, Valdés-Márquez, et al.
Publicado: (2011)

Central statistical monitoring in multicentre clinical trials: developing statistical approaches for analysing key risk indicators
por: Valdes-Marquez, Elsa, et al.
Publicado: (2013)

Association of CETP Gene Variants With Risk for Vascular and Nonvascular Diseases Among Chinese Adults
por: Millwood, Iona Y., et al.
Publicado: (2017)

Improving efficiency of on-site monitoring in multicentre clinical trials by targeting visits
por: Knott, Carol, et al.
Publicado: (2015)

Impact of ADCY9 Genotype on Response to Anacetrapib
por: Hopewell, Jemma C., et al.
Publicado: (2019)

Association of Preexisting Disability With Severe Maternal Morbidity or Mortality in Ontario, Canada
por: Brown, Hilary K., et al.
Publicado: (2021)

Long-term post-trial follow-up of participants in randomised trials: lessons learned from the mrc / bhf heart protection study (HPS)
por: Aung, Theingi, et al.
Publicado: (2013)

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
por: Haynes, Richard, et al.
Publicado: (2013)

Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data
por: Harper, Charlie, et al.
Publicado: (2023)

Post-trial follow-up methodology in large randomized controlled trials: a systematic review protocol
por: Llewellyn-Bennett, Rebecca, et al.
Publicado: (2016)

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
por: Mihaylova, Borislava, et al.
Publicado: (2016)

The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
por: Parish, Sarah, et al.
Publicado: (2009)

The role of lipoprotein (a) in chronic kidney disease
por: Hopewell, Jemma C., et al.
Publicado: (2018)

Genetic associations of adult height with risk of cardioembolic and other subtypes of ischemic stroke: A mendelian randomization study in multiple ancestries
por: Linden, Andrew B., et al.
Publicado: (2022)

Vitamin D and Calcium for the Prevention of Fracture: A Systematic Review and Meta-analysis
por: Yao, Pang, et al.
Publicado: (2019)

ASCEND: A Study of Cardiovascular Events iN Diabetes: Characteristics of a randomized trial of aspirin and of omega-3 fatty acid supplementation in 15,480 people with diabetes
por: Bowman, Louise, et al.
Publicado: (2018)

The Limits to Parapatric Speciation II: Strengthening a Preexisting Genetic Barrier to Gene Flow in Parapatry
por: Blanckaert, Alexandre, et al.
Publicado: (2018)

Assessment of the Role of Carotid Atherosclerosis in the Association Between Major Cardiovascular Risk Factors and Ischemic Stroke Subtypes
por: Parish, Sarah, et al.
Publicado: (2019)

Age-specific association between blood pressure and vascular and non-vascular chronic diseases in 0·5 million adults in China: a prospective cohort study
por: Lacey, Ben, et al.
Publicado: (2018)

Lipoprotein-Associated Phospholipase A(2) Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults
por: Millwood, Iona Y., et al.
Publicado: (2016)

Lymphotoxin-α Gene and Risk of Myocardial Infarction in 6,928 Cases and 2,712 Controls in the ISIS Case-Control Study
por: Clarke, Robert, et al.
Publicado: (2006)

Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China
por: Millwood, Iona Y, et al.
Publicado: (2019)

Association of Physical Activity With Risk of Major Cardiovascular Diseases in Chinese Men and Women
por: Bennett, Derrick A., et al.
Publicado: (2017)

Effect of low-dose aspirin on urinary 11-dehydro-thromboxane B2 in the ASCEND (A Study of Cardiovascular Events iN Diabetes) randomized controlled trial
por: Parish, Sarah, et al.
Publicado: (2023)

Quality by design: using intelligent forms to ensure study protocol compliance and participant safety
por: Dayanandan, Rejive, et al.
Publicado: (2015)

Methodology for UK recruitment into a large-scale international clinical trial
por: Wincott, Elizabeth, et al.
Publicado: (2015)

A Biomarker-based Biological Age in UK Biobank: Composition and Prediction of Mortality and Hospital Admissions
por: Chan, Mei Sum, et al.
Publicado: (2021)

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease
por: Sammons, E, et al.
Publicado: (2021)

Post-trial follow-up methodology in large randomised controlled trials: a systematic review
por: Llewellyn-Bennett, Rebecca, et al.
Publicado: (2018)

Sclerotherapy as an esthetic indication in oral vascular malformations: a case series()()
por: Manzano, Brena Rodrigues, et al.
Publicado: (2019)

Physical Activity, Sedentary Leisure Time, Circulating Metabolic Markers, and Risk of Major Vascular Diseases
por: Pang, Yuanjie, et al.
Publicado: (2019)

Recruiting patients cost-effectively by mail
por: Aung, Theingi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p53n28js2jiug22jsgi0930r4a